ArticlePediatric research2026
Gorm Greisen and the transformation of our understanding of newborn brain physiology: a tribute on the occasion of his retirement, on behalf of the ESPR NIRS Special Interest Group.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This INSIGHT contribution honours Professor Gorm Greisen on the occasion of his retirement and recognises his profound influence on neonatal brain physiology and care, on behalf of the Near-Infrared Spectroscopy (NIRS) Special Interest Group of the European Society for Paediatric Research. Over more than four decades, Greisen reshaped our understanding of cerebral hemodynamics and the distinctive vulnerabilities of the newborn brain during the transitional period after birth. Through methodological innovation combined with careful physiological enquiry, he contributed decisively to establishing non-invasive cerebral monitoring as a scientifically robust clinical tool and clarified the limits of autoregulation and oxygen-metabolic balance in both preterm and term infants. Beyond his scientific achievements, Greisen has played a central role in international collaborative research, helping to define standards for physiologic trials in neonatology and to cultivate a coherent global research community. His enduring commitment to methodological rigour, thoughtful interpretation, and ethical reflection has influenced clinical practice as well as academic culture. His legacy persists in the conceptual frameworks, collaborative networks, and values that continue to guide efforts to safeguard the developing brain.
Identifiers
42032187What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.